Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort).
Jietao LinLingling SunHanrui ChenWenmin ChenZexin ZhangYang CaoLi-Zhu LinPublished in: Integrative cancer therapies (2023)
The institutional review board and ethics committee reviewed the study protocol. All patients will provide informed consent before enrollment.Trial registration number: ChiCTR1900021430.
Keyphrases
- study protocol
- end stage renal disease
- clinical trial
- randomized controlled trial
- small cell lung cancer
- newly diagnosed
- chronic kidney disease
- south africa
- ejection fraction
- public health
- peritoneal dialysis
- prognostic factors
- healthcare
- phase iii
- health insurance
- network analysis
- patient reported outcomes
- advanced non small cell lung cancer
- double blind